HomeADCT • NYSE
ADC Therapeutics SA
Follow
$3.15
4.55%
After Hours:(0.00%)0.00
$3.15
Closed: Jul 11, 7:49:06 PM GMT-4 · USD · NYSE · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 23.03M | 27.59% |
Operating expense | 49.44M | 0.57% |
Net income | -38.60M | 17.17% |
Net profit margin | -167.59 | 35.08% |
Earnings per share | — | — |
EBITDA | -28.12M | 15.50% |
Effective tax rate | -0.43% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 194.70M | -16.90% |
Total assets | 272.54M | -11.50% |
Total liabilities | 510.76M | 1.66% |
Total equity | -238.22M | — |
Shares outstanding | 99.18M | — |
Price to book | -1.38 | — |
Return on assets | -23.94% | — |
Return on capital | -31.48% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -38.60M | 17.17% |
Cash from operations | -56.33M | -27.76% |
Cash from investing | -264.00K | 50.28% |
Cash from financing | 271.00K | -23.88% |
Net change in cash | -56.17M | -26.75% |
Free cash flow | -46.27M | -93.87% |
Previous close
$3.30
Day range
$3.13 - $3.30
Year range
$1.05 - $4.13
Market cap
312.41M USD
Avg Volume
943.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
About
Founded
2011
Website
Employees
264